Evidence map›Paper›PMID 32115900›Full record

ArticleFEBS open bio2020

Characterisation of a novel cold-adapted calcium-activated transglutaminase: implications for medicine and food processing.

Rebeca Garcia Alvarez, Pralav Karki, Ida Elise Langleite, Ragna-Johanne Bakksjø, Lutz Andreas Eichacker, Clemens Furnes

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rebeca Garcia AlvarezCentre for Organelle Research, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.
Pralav KarkiCentre for Organelle Research, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.
Ida Elise LangleiteCentre for Organelle Research, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.
Ragna-Johanne BakksjøCentre for Organelle Research, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.
Lutz Andreas EichackerCentre for Organelle Research, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.
Clemens FurnesCentre for Organelle Research, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.ORCID 0000-0002-8378-5354
University of Stavanger · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transglutaminases are a family of enzymes that catalyse the cross-linking of proteins by forming covalent bonds between lysine and glutamine residues in various polypeptides. Cross-linking reactions are involved in blood clots, skin formation, embryogenesis and apoptosis. Clinically, these enzymes appear to be implicated in neurodegenerative diseases, tumours and coeliac diseases. Transglutaminases have great potential for use in the food industry because of their ability to cross-link proteins that are not normally linked. Here, a gene coding for transglutaminase from Atlantic cod was cloned into a bacterial expression vector and used to transform protein expression in a strain of Escherichia coli. The successful expression of recombinant transglutaminase protein from Atlantic cod (AcTG-1) as a soluble protein upon induction at low temperature was confirmed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis, immunoblotting and mass spectrometry analysis. Biochemical characterisation demonstrated that the transglutaminase was active between 0 and 65 °C, but was completely inactivated after 20-min incubation at 70 °C. Interestingly, the enzyme displayed cold-adapted features, such as temperature instability combined with high catalytic efficiency at low temperatures (8-16 °C). In addition, the enzyme had optimal activity at 50 °C, a new feature for a cold-adapted enzyme. AcTG-1 was active in the pH range from 6 to 9, with an optimum at pH 8, and required 5 mm calcium for maximum activity. Potential calcium-binding sites in the enzyme were predictable, making the enzyme an appropriate model for studying structure-function relationships in the calcium-dependent transglutaminase family. In vitro gel analysis revealed that transglutaminase cross-linked casein, collagen and gelatin. The binding of fish fillets in the presence of recombinant AcTG-1 provided further macroscopic proof for the potential application of AcTG-1 as a biological cross-linker in the food industry. Once binding occurred, fish fillets withstood further processing such as frying, boiling, freeze-thawing and chilling. The low-temperature activity and new enzymatic properties of AcTG-1 appear to offer advantages over commercially available enzymatic glues in the food industry.

Indexed as

Cold TemperatureFood HandlingMedicineAdhesivesAnimalsCalciumCaseinsCollagenCross-Linking ReagentsEnzyme ActivationEscherichia coliGadus morhuaGelatinGlutamineHydrogen-Ion ConcentrationLysineAdhesivesCalciumCaseinsCollagenCross-Linking ReagentsGelatinGlutamineLysinePeptidesRecombinant ProteinsTransglutaminasesAtlantic codcalcium-dependentcold adaptionrecombinant expressiontransglutaminase

Identifiers

PMID32115900
PMCPMC7137806
OpenAlexW3010296418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.